Skip to content
OpenCapital
Get started

West Pharmaceutical Services WST Ratios & Valuation

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin36.3%+0.4pp35.9%+0.3pp35.6%+0.3pp35.3%+0.7pp34.5%0.0pp
Operating margin20.3%+1.3pp19%-0.5pp19.5%-0.2pp19.6%+0.5pp19.1%-0.6pp
Net margin16.8%+0.8pp16.1%-0.2pp16.3%-0.2pp16.5%+0.3pp16.1%-0.9pp
EBITDA margin25.8%+1.2pp24.6%-0.3pp24.9%-0.2pp25.1%+0.5pp24.6%-0.4pp
Free cash flow margin14.2%-1.0pp15.3%+2.7pp12.6%+0.9pp11.6%+1.0pp10.6%+1.0pp
Returns
Return on equity19.1%+2.3pp16.9%-0.1pp16.9%-0.8pp17.7%+0.3pp17.4%-0.3pp
Return on assets14%+1.6pp12.5%-0.2pp12.6%-0.5pp13.1%+0.2pp12.9%-0.2pp
Return on invested capital19.2%+1.3pp17.9%+0.3pp17.6%-0.2pp17.8%+0.1pp17.8%-1.5pp
Efficiency
Asset turnover0.8×+0.1×0.8×0.0×0.8×0.0×0.8×0.0×0.8×0.0×
Inventory turnover4.9×+0.1×4.8×+0.2×4.6×+0.1×4.6×-0.1×4.6×0.0×
Liquidity
Current ratio2.7×-0.3×3×+0.2×2.9×+0.1×2.8×0.0×2.8×0.0×
Quick ratio2×-0.3×2.3×+0.2×2.2×+0.1×2.1×+0.1×2×-0.1×
Cash ratio0.8×-0.4×1.2×+0.2×1×+0.1×0.8×+0.1×0.8×-0.1×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Net debt / EBITDA-0.2×+0.4×-0.6×-0.2×-0.4×-0.2×-0.3×-0.1×-0.1×+0.1×
Per Share
Book value per share$41.30-5.5%$43.69+3.9%$42.03+4.0%$40.40+9.9%$36.75+1.0%
Valuation
Market capitalization$18.07B-8.7%$19.79B+4.9%$18.86B+17.9%$16B-1.2%$16.18B-31.8%
Enterprise value$17.87B-7.6%$19.33B+4.3%$18.54B+17.4%$15.8B-1.8%$16.09B-31.7%
Price / earnings33.3×-6.8×40.1×+1.7×38.4×+5.6×32.8×-1.8×34.6×-13.5×
Price / sales5.6×-0.8×6.4×+0.2×6.3×+0.8×5.4×-0.2×5.6×-2.6×
Price / book6×-0.2×6.2×+0.1×6.2×+0.7×5.5×-0.6×6×-2.8×
EV / EBITDA21.5×-4.1×25.6×+0.9×24.6×+3.4×21.3×-1.3×22.6×-9.9×
EV / sales5.5×-0.7×6.3×+0.1×6.1×+0.8×5.3×-0.2×5.6×-2.6×
Free cash flow yield2.5%+0.2pp2.4%+0.4pp2%-0.1pp2.2%+0.3pp1.9%+0.7pp
Earnings yield3%+0.5pp2.5%-0.1pp2.6%-0.4pp3%+0.2pp2.9%+0.8pp
Dividend yield0.3%0.0pp0.3%0.0pp0.3%-0.1pp0.4%0.0pp0.4%+0.1pp
PEG ratio2.1×-195×197.5×———————

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are West Pharmaceutical Services's profit margins?
West Pharmaceutical Services (WST) runs a 36.3% gross margin and a 20.3% operating margin, with a 16.8% net margin.
Where do West Pharmaceutical Services's ratios come from?
Every ratio is computed from West Pharmaceutical Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.